These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31882917)

  • 1. Real-world safety evaluation of musculoskeletal adverse events associated with Korean pediatric fluoroquinolone use: a nationwide longitudinal retrospective cohort study.
    Kim Y; Paik M; Khan C; Kim YJ; Kim E
    Sci Rep; 2019 Dec; 9(1):20156. PubMed ID: 31882917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between recent use of fluoroquinolones and rhegmatogenous retinal detachment: a population-based cohort study.
    Kuo SC; Chen YT; Lee YT; Fan NW; Chen SJ; Li SY; Liu CJ; Chen TL; Chen TJ; Fung CP
    Clin Infect Dis; 2014 Jan; 58(2):197-203. PubMed ID: 24170197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone safety in pediatric patients: a prospective, multicenter, comparative cohort study in France.
    Chalumeau M; Tonnelier S; D'Athis P; Tréluyer JM; Gendrel D; Bréart G; Pons G;
    Pediatrics; 2003 Jun; 111(6 Pt 1):e714-9. PubMed ID: 12777590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Do fluoroquinolones commonly cause arthropathy in children?
    Forsythe CT; Ernst ME
    CJEM; 2007 Nov; 9(6):459-62. PubMed ID: 18072993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Fluoroquinolones on Outcomes of Patients With Aortic Dissection or Aneurysm.
    Chen SW; Chan YH; Chien-Chia Wu V; Cheng YT; Chen DY; Lin CP; Hung KC; Chang SH; Chu PH; Chou AH
    J Am Coll Cardiol; 2021 Apr; 77(15):1875-1887. PubMed ID: 33858624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of the risk of musculoskeletal adverse events associated with fluoroquinolone use in children: A meta-analysis.
    Wang JG; Cui HR; Hu YS; Tang HB
    Medicine (Baltimore); 2020 Aug; 99(34):e21860. PubMed ID: 32846837
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of retinal tear or detachment with oral fluoroquinolone use: a cohort study.
    Eftekhari K; Ghodasra DH; Haynes K; Chen J; Kempen JH; VanderBeek BL
    Pharmacoepidemiol Drug Saf; 2014 Jul; 23(7):745-52. PubMed ID: 24757075
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serious cardiovascular adverse events with fluoroquinolones versus other antibiotics: A self-controlled case series analysis.
    Aspinall SL; Sylvain NP; Zhao X; Zhang R; Dong D; Echevarria K; Glassman PA; Goetz MB; Miller DR; Cunningham FE
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00664. PubMed ID: 33047487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Administration of oral fluoroquinolone and the risk of rhegmatogenous retinal detachment: A nationwide population-based study in Korea.
    Choi SY; Lim HA; Yim HW; Park YH
    PLoS One; 2018; 13(4):e0195563. PubMed ID: 29649310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Fluoroquinolones and the Risk of Uveitis.
    Sandhu HS; Brucker AJ; Ma L; VanderBeek BL
    JAMA Ophthalmol; 2016 Jan; 134(1):38-43. PubMed ID: 26512796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluoroquinolones and collagen associated severe adverse events: a longitudinal cohort study.
    Daneman N; Lu H; Redelmeier DA
    BMJ Open; 2015 Nov; 5(11):e010077. PubMed ID: 26582407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic fluoroquinolone prescriptions for hospitalized children in Belgium, results of a multicenter retrospective drug utilization study.
    Meesters K; Mauel R; Dhont E; Walle JV; De Bruyne P
    BMC Infect Dis; 2018 Feb; 18(1):89. PubMed ID: 29471791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fluoroquinolone use in a rural practice.
    Kelly L; Schreiber YS; Hopko J; Kirkwood T; Kattini R; Poirier D; Madden S
    Can J Rural Med; 2021; 26(1):14-18. PubMed ID: 33380601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of collagen-associated adverse events in pediatric population with the use of fluoroquinolones: a nationwide cohort study in Taiwan.
    Yu PH; Hu CF; Liu JW; Chung CH; Chen YC; Sun CA; Chien WC
    BMC Pediatr; 2020 Feb; 20(1):64. PubMed ID: 32046672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and Tolerability of Moxifloxacin in Children.
    Dixit A; Karandikar MV; Jones S; Nakamura MM
    J Pediatric Infect Dis Soc; 2018 Aug; 7(3):e92-e101. PubMed ID: 29939314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A VigiBase descriptive study of fluoroquinolone induced disabling and potentially permanent musculoskeletal and connective tissue disorders.
    Huruba M; Farcas A; Leucuta DC; Bucsa C; Sipos M; Mogosan C
    Sci Rep; 2021 Jul; 11(1):14375. PubMed ID: 34257376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of FDA Boxed Warning on Prescribing Patterns of Fluoroquinolones for Uncomplicated Urinary Tract Infections.
    Cowart K; Worley M; Rouby NE; Sando K
    Ann Pharmacother; 2019 Dec; 53(12):1192-1199. PubMed ID: 31319681
    [No Abstract]   [Full Text] [Related]  

  • 19. Emergence of quinolone resistance in the microbiota of hospitalized patients treated or not with a fluoroquinolone.
    de Lastours V; Chau F; Roy C; Larroque B; Fantin B
    J Antimicrob Chemother; 2014 Dec; 69(12):3393-400. PubMed ID: 25063781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation.
    Etminan M; Sodhi M; Ganjizadeh-Zavareh S; Carleton B; Kezouh A; Brophy JM
    J Am Coll Cardiol; 2019 Sep; 74(11):1444-1450. PubMed ID: 31514945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.